← Back to Search

Social Network Intervention for HIV Prevention

N/A

Waitlist Available

Led By Oluwaseun Falade-Nwulia, MBBS, MPH

Research Sponsored by Johns Hopkins University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged 18 or older

Be older than 18 years old

Must not have

Individuals lacking the capacity to consent

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months, 9-months

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to increase HIV testing & PrEP knowledge and uptake of HIV & medication for opioid use disorder in Maryland using a social network intervention.

Who is the study for?

This trial is for adults over 18 in Maryland who use syringe service programs and can recruit at least one drug-using peer. They must speak English, be willing to undergo training, and discuss HIV prevention. People unable to consent are excluded.

What is being tested?

The study tests if a peer-educator network can increase HIV testing, PrEP knowledge, uptake of HIV services/PrEP, and medication for opioid use disorder among people who inject drugs compared to an overdose education control group.

What are the potential side effects?

Since the intervention involves education and social networking rather than medical treatment, there are no direct side effects from medications or procedures; however, discussing sensitive health topics may cause discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am unable to make medical decisions for myself.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months, 9-months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months, 9-months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months, 9-months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Proportion of HIV testing for Network Members

Secondary study objectives

Change in Knowledge of PrEP options

Proportion of HIV negative participants who have used PrEP uptake

Proportion of HIV testing for Index Members

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Peer-educator-based network interventionExperimental Treatment1 Intervention

Indexes randomized to the intervention arm will complete a training program that emphasizes effective communication, frequent HIV testing, and awareness of evidence-based HIV prevention and treatment services. An important innovation to the network intervention will be training indexes to use and distribute HIV self-test kits and naloxone to their network members (NMs).

Group II: Equal-attention controlActive Control1 Intervention

This group will receive training sessions that will be focused on the opioid overdose epidemic and will not include any training to serve as a peer educator.

0 / 2Eligibility criteria met